Article
AI Generated Stromal Biomarkers for DCIS Reccurence Prediction
2026-02-17
Abstract excerpt
<h4>Background</h4> Although DCIS has a relatively low recurrence rate, many patients still receive adjuvant radiotherapy or endocrine therapy, raising concerns about overtreatment. Reliable biomarkers are therefore needed to predict an individual patient’s risk and guide treatment decisions. Recent studies suggest that the composition of the tumour-associated stroma (TAS) affects progression and outcome, highlig...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8d47e5d7-2aed-512f-9080-9593a412c0f3
- DOI
- 10.64898/2026.02.13.26346278
